Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Trifluridine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 31 Colonic Neoplasms 8 Rectal Neoplasms 7 Neoplasm Metastasis 4 Neoplasms 3 Stomach Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Gastric and Gastroesophageal Junction Adenocarcinoma 1 Gastric Cancer Adenocarcinoma Metastatic 1 Gastric Adenocarcinoma 1 Gallbladder Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

Cisplatin 43 Carboplatin 38 pembrolizumab 36 Paclitaxel 32 Gemcitabine 27 Pemetrexed 18 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Radiotherapy, Intensity-Modulated 16 Docetaxel 16 Cetuximab 16 Nivolumab 14 Specimen Handling 13 Cyclophosphamide 13 durvalumab 12 Fluorouracil 12 Sorafenib 10 130-nm albumin-bound paclitaxel 10 Sunitinib 9 Platinum 9 Bevacizumab 9 osimertinib 8 Radiation 8 1,2-diaminocyclohexaneplatinum II citrate 8 Oxaliplatin 7 Irinotecan 7 Everolimus 7 Drug Therapy 7 Capecitabine 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡